Covered recipient · General Payments record
MARCY A GALINSKY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,224.72
- Reported across 60 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $321.27 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $113.57 | 7 |
| PFIZER INC. | $68.78 | 3 |
| Novo Nordisk AS | $57.57 | 3 |
| Exact Sciences Corporation | $44.28 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $21.65 | 1 |
| Paratek Pharmaceuticals, Inc. | $15.42 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Exact Sciences Corporation | $21.24 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114666290 | CMS |
| Exact Sciences Corporation | $23.04 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114666295 | CMS |
| Lilly USA, LLC | $14.06 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135148780 | CMS |
| Lilly USA, LLC | $15.18 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135148778 | CMS |
| Lilly USA, LLC | $14.00 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135164813 | CMS |
| Lilly USA, LLC | $14.62 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135164437 | CMS |
| Lilly USA, LLC | $18.80 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135164439 | CMS |
| Lilly USA, LLC | $18.11 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135164441 | CMS |
| Lilly USA, LLC | $18.80 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135107773 | CMS |
| Novartis Pharmaceuticals Corporation | $21.65 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086956735 | CMS |
| Novo Nordisk Inc | $22.83 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097159207 | CMS |
| Novo Nordisk Inc | $15.99 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096616628 | CMS |
| Novo Nordisk Inc | $18.75 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097672483 | CMS |
| Paratek Pharmaceuticals, Inc. | $15.42 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113900491 | CMS |
| PFIZER INC. | $19.98 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132031788 | CMS |
| PFIZER INC. | $25.56 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131216085 | CMS |
| PFIZER INC. | $23.24 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131686150 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.